- Home
- COCP vs TXMD Comparison
COCP vs TXMD Comparison
Compare COCP & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCP
- TXMD
- Stock Information
- Founded
- COCP N/A
- TXMD 2008
- Country
- COCP United States
- TXMD United States
- Employees
- COCP N/A
- TXMD N/A
- Industry
- COCP Biotechnology: Pharmaceutical Preparations
- TXMD Biotechnology: Pharmaceutical Preparations
- Sector
- COCP Health Care
- TXMD Health Care
- Exchange
- COCP Nasdaq
- TXMD Nasdaq
- Market Cap
- COCP 18.2M
- TXMD 17.6M
- IPO Year
- COCP N/A
- TXMD N/A
- Fundamental
- Price
- COCP $2.04
- TXMD $1.58
- Analyst Decision
- COCP Strong Buy
- TXMD
- Analyst Count
- COCP 1
- TXMD 0
- Target Price
- COCP $7.00
- TXMD N/A
- AVG Volume (30 Days)
- COCP 18.6K
- TXMD 14.7K
- Earning Date
- COCP 11-11-2024
- TXMD 11-12-2024
- Dividend Yield
- COCP N/A
- TXMD N/A
- EPS Growth
- COCP N/A
- TXMD N/A
- EPS
- COCP N/A
- TXMD N/A
- Revenue
- COCP N/A
- TXMD $996,000.00
- Revenue This Year
- COCP N/A
- TXMD $605.07
- Revenue Next Year
- COCP N/A
- TXMD $1.11
- P/E Ratio
- COCP N/A
- TXMD N/A
- Revenue Growth
- COCP N/A
- TXMD N/A
- 52 Week Low
- COCP $1.33
- TXMD $1.43
- 52 Week High
- COCP $3.10
- TXMD $3.07
- Technical
- Relative Strength Index (RSI)
- COCP 61.73
- TXMD 42.62
- Support Level
- COCP $1.66
- TXMD $1.59
- Resistance Level
- COCP $1.87
- TXMD $1.62
- Average True Range (ATR)
- COCP 0.15
- TXMD 0.07
- MACD
- COCP 0.04
- TXMD -0.00
- Stochastic Oscillator
- COCP 48.10
- TXMD 31.58
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.